Related Experiment Video
Updated: Apr 15, 2026

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
[Management of side effects of targeted therapies in renal cancer: cutaneous side effects]
Caroline Robert1, Pierre Gimel2
1Institut Gustave-Roussy, service de dermatologie, 39, rue Camille-Desmoulins, 94805 Villejuif Cedex, France.
Abstract:
Targeted therapies used (angiogenesis inhibitors and mTOR inhibitors) in advanced renal cell carcinoma have a constellation of reaction affecting the skin, hair and nails. This guideline describes the incidence, clinical presentation and treatment of dermatologic side effects that develop with the use of targeted therapies (sunitinib, sorafenib, pazopanib, bevacizumab, everolimus, temsirolimus).
Insights
Targeted cancer therapies, including angiogenesis and mTOR inhibitors, can cause skin, hair, and nail side effects in advanced renal cell carcinoma patients. This guideline details managing these common dermatologic reactions.
Area of Science:
- Oncology
- Dermatology
- Pharmacology
Context:
- Advanced renal cell carcinoma (RCC) treatment often involves targeted therapies.
- Angiogenesis inhibitors and mTOR inhibitors are key targeted therapies for advanced RCC.
- These therapies can cause significant dermatologic adverse events.
Purpose:
- To describe the incidence and clinical presentation of skin, hair, and nail side effects.
- To provide treatment guidelines for managing these dermatologic reactions.
- To inform clinicians on managing side effects from specific targeted therapies like sunitinib, sorafenib, pazopanib, bevacizumab, everolimus, and temsirolimus.
Summary:
- Targeted therapies for advanced renal cell carcinoma frequently cause dermatologic side effects.
- Common reactions affect the skin, hair, and nails.
- Management strategies for these side effects are outlined.
Impact:
- Improved patient quality of life during cancer treatment.
- Enhanced adherence to necessary targeted therapies.
- Better understanding and management of drug-induced dermatologic conditions in oncology.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies
Nephrotic Syndrome III : Nursing Management
Kidney Transplant III: Nursing Management
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

